Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has provided an announcement.
Charmacy Pharmaceutical Co., Ltd. announced the successful passing of all resolutions during its Annual General Meeting held on May 22, 2025. Key resolutions included the approval of the 2024 financial statements, amendments to meeting procedures, and the distribution of the 2024 final dividend. The company also approved a comprehensive revolving credit line of up to RMB 2.8 billion, which is expected to enhance its financial flexibility and support future operations.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a pharmaceutical company based in China, primarily engaged in the production and distribution of pharmaceutical products. The company focuses on providing a wide range of pharmaceutical solutions to meet market demands.
Average Trading Volume: 2,842
Technical Sentiment Signal: Sell
Current Market Cap: HK$831.6M
For a thorough assessment of 2289 stock, go to TipRanks’ Stock Analysis page.